IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 1 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $0 | – | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 2,000 | -87.9% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 16,540 | -0.8% | 0.00% | – |
| Q2 2014 | $17,000 | 0.0% | 16,680 | 0.0% | 0.00% | – |
| Q1 2014 | $17,000 | – | 16,680 | 0.0% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 16,680 | 0.0% | 0.00% | – |
| Q3 2013 | $33,000 | -95.1% | 16,680 | -95.2% | 0.00% | – |
| Q2 2013 | $672,000 | – | 346,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Callan Capital, LLC | 70,000 | $180,000 | 0.09% |
| Ifrah Financial Services, Inc. | 28,500 | $73,000 | 0.04% |
| CHELSEA COUNSEL CO | 28,000 | $72,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,000 | $450,000 | 0.02% |
| Highlander Capital Management, LLC | 5,000 | $12,850,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 154,815 | $398,000 | 0.01% |
| Gerstein Fisher | 10,000 | $26,000 | 0.01% |
| First Allied Advisory Services, Inc. | 40,000 | $103,000 | 0.01% |
| Wellington Shields Capital Management, LLC | 10,000 | $26,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 123,857 | $318,000 | 0.00% |